Clinical Chemistry and Laboratory Medicine (CCLM)
Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Editor-in-Chief: Plebani, Mario
Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.
IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition
SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238
Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes
1Institute of Analytical Chemistry and Radiochemistry, Leopold Franzens University, Innsbruck, Austria and Biocrates Life Sciences AG, Innsbruck, Austria
2Biocrates Life Sciences AG, Innsbruck, Austria
3Institute of Analytical Chemistry and Radiochemistry, Leopold Franzens University, Innsbruck, Austria
4Biocrates Life Sciences AG, Innsbruck, Austria
Current address: CSL Limited, 45 Poplar Road, Parkville, VIC 3052, Australia.
5Biocrates Life Sciences AG, Innsbruck, Austria
Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 46, Issue 11, Pages 1589–1597, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.323, October 2008
- Published Online:
Background: Fatty acid metabolites play a key role in numerous physiological and pathological processes. A rapid liquid chromatography-mass spectrometry assay for the simultaneous determination of prostanoids, isoprostane and lipoxygenase (LOX) derived fatty acid metabolites in a small biological sample of only 20 μL was developed.
Methods: Human plasma samples were applied to a filter spot, extracted without prior derivatization and analyzed within 13 min. Detection of metabolites was performed on a triple quadrupole mass spectrometer in negative multiple-reaction monitoring detection mode. Application of this assay to various biological matrices was performed.
Results: The validated assay was linear over the concentration range of 5–500 nmol/L for prostanoids and isoprostane, 50–5000 nmol/L for LOX-derived metabolites and 400–40,000 nmol/L for fatty acids. Limits of quantitation were 0.4–233 nmol/L, depending on the metabolite. Plasma samples from diabetic patients and controls showed significant increases in (±)9-HODE and 15(S)-HETE with p-values of 0.019 and 0.024, respectively.
Conclusions: The small amount of 20 μL sample volume used in this assay and the demonstrated application to various sample types makes it an ideal routine analysis method for fatty acid metabolites. The resulting values for LOX-derived metabolites in diabetes mellitus type 2 samples support earlier findings about the role of lipid oxidation products in diabetes.
Clin Chem Lab Med 2008;46:1589–97.
Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.